Immediate versus deferred androgen-deprivation therapy for prostate cancer: the jury is still out

被引：0
|
作者：
Alexandre R Zlotta
Claude Schulman
机构：
[1] Senior Faculty in Urology at the University Clinics of Brussels in Brussels,Chief of the Department of Urology at Erasme Hospital
[2] University Clinics of Brussels,undefined
[3] and a Professor of Urology at the University of Brussels,undefined
来源：
Nature Clinical Practice Urology | 2006年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：474 / 475
页数：1
相关论文
共 50 条
  • [41] Androgen-Deprivation Therapy in Prostate Cancer: A European Expert Panel Review
    Schulman, Claude C.
    Irani, Jacques
    Morote, Juan
    Schalken, Jack A.
    Montorsi, Francesco
    Chlosta, Piotr L.
    Heidenreich, Axel
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (07) : 675 - 691
  • [42] Androgen-deprivation Therapy and Risk for Biliary Disease in Men with Prostate Cancer
    Saylor, Philip J.
    Smith, Matthew R.
    O'Malley, A. James
    Keating, Nancy L.
    EUROPEAN UROLOGY, 2014, 65 (03) : 642 - 649
  • [43] Psychological Effects of Androgen-Deprivation Therapy on Men With Prostate Cancer and Their Partners
    Donovan, Kristine A.
    Walker, Lauren M.
    Wassersug, Richard J.
    Thompson, Lora M. A.
    Robinson, John W.
    CANCER, 2015, 121 (24) : 4286 - 4299
  • [44] Effectiveness of Primary Androgen-Deprivation Therapy for Clinically Localized Prostate Cancer
    Potosky, Arnold L.
    Haque, Reina
    Cassidy-Bushrow, Andrea E.
    Yood, Marianne Ulcickas
    Jiang, Miao
    Tsai, Huei-Ting
    Luta, George
    Keating, Nancy L.
    Smith, Matthew R.
    Van Den Eeden, Stephen K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (13) : 1324 - +
  • [45] COMPLICATIONS OF ANDROGEN-DEPRIVATION THERAPY IN PROSTATE CANCER: THE OTHER SIDE OF THE COIN
    Hoffmann, Paul
    Schulman, Claude
    BJU INTERNATIONAL, 2009, 103 (08) : 1020 - 1023
  • [46] Adjuvant Androgen-Deprivation Therapy for Prostate Cancer Should Docetaxel Be Added?
    Vogelzang, Nicholas J.
    JAMA ONCOLOGY, 2019, 5 (05) : 633 - 634
  • [47] A structured debate: Immediate versus deferred androgen suppression in prostate cancer - Evidence for deferred treatment
    Kirk, D
    JOURNAL OF UROLOGY, 2002, 167 (02): : 652 - 652
  • [48] A structured debate: Immediate versus deferred androgen suppression in prostate cancer - Evidence for deferred treatment
    Walsh, PC
    DeWeese, TL
    Eisenberger, MA
    JOURNAL OF UROLOGY, 2001, 166 (02): : 508 - 515
  • [49] Androgen-deprivation therapy versus radical prostatectomy as monotherapy among clinically localized prostate cancer patients
    Liu, Jinan
    Shi, Lizheng
    Sartor, Oliver
    Culbertson, Richard
    ONCOTARGETS AND THERAPY, 2013, 6 : 725 - 732
  • [50] Androgen-Deprivation Therapy for Prostate Cancer and Rise in HbA1C
    DeCarlo, K. E.
    Blachman, N. L.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 : S91 - S91
12345